The 5-HT 2A receptor and serotonin transporter in Asperger's Disorder: A PET study with [ 11C]MDL 100907 and [ 11C]DASB

Psychiatry Research - Neuroimaging

Volumn 194, Issue 3, 2011, Pages 230-234

  Girgis, Ragy R ^a   Slifstein, Mark ^a   Xu, Xiaoyan ^a   Frankle, W Gordon ^b   Anagnostou, Evdokia ^c   Wasserman, Stacey ^d   Pepa, Lauren ^d   Kolevzon, Alexander ^d   Abi Dargham, Anissa ^a   Laruelle, Marc ^a,e   Hollander, Eric ^f  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

5 HT 2A receptor; Asperger's Disorder; Autism spectrum disorders; Positron emission tomography; Serotonin; Serotonin transporter

Indexed keywords

DASB C 11; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; TRACER; UNCLASSIFIED DRUG; VOLINANSERIN C 11;

ADULT; ARTICLE; ASPERGER SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUROCHEMISTRY; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING;

ADOLESCENT; ADULT; ASPERGER SYNDROME; BENZYLAMINES; BRAIN MAPPING; CARBON RADIOISOTOPES; FEMALE; FLUOROBENZENES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PIPERIDINES; POSITRON-EMISSION TOMOGRAPHY; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN ANTAGONISTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; YOUNG ADULT;

EID: 82455164162     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2011.04.007     Document Type: Article

References (25)

1. 11C]NNC 112 in humans: validation and reproducibility. Journal of Cerebral Blood Flow and Metabolism 2000, 20:225-243.
2. 11C]NNC 756. Synapse 1999, 32:93-109.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, APA, Washington, DC.
4. Ashburner J., Friston K. Multimodal image coregistration and partitioning - a unified framework. Neuroimage 1997, 6:209-217.
5. Chugani D.C., Muzik O., Rothermel R., Behen M., Chakraborty P., Mangner T., Chugani H.T. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Annals of Neurology 1997, 42:666-669.
6. Frankle W.G., Huang Y., Hwang D.R., Talbot P.S., Slifstein M., Van Heertum R., Abi-Dargham A., Laruelle M. Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans. Journal of Nuclear Medicine 2004, 45:682-694.
7. Frankle W.G., Slifstein M., Gunn R.N., Huang Y., Hwang D.R., Darr E.A., Narendran R., Abi-Dargham A., Laruelle M. Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods. Journal of Nuclear Medicine 2006, 47:815-826.
8. Goldberg J., Anderson G.M., Zwaigenbaum L., Hall G.B., Nahmias C., Thompson A., Szatmari P. Cortical serotonin type-2 receptor density in parents of children with autism spectrum disorders. Journal of Autism and Developmental Disorders 2009, 39:97-104.
9. 11C]DASB. European Journal of Nuclear Medicine 2000, 27:1719-1722.
10. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. Journal of Cerebral Blood Flow and Metabolism 2007, 27:1533-1539.
11. Ito H., Nyberg S., Halldin C., Lundvist C., Farde L. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. Journal of Nuclear Medicine 1998, 39:208-214.
12. Laruelle M., Baldwin R.M., Malison R.T., Zeaponce Y., Zoghbi S.S., Altikriti M.S., Sybirska E.H., Zimmermann R.C., Wisniewski G., Neumeyer J.L., Milius R.A., Wang S.Y., Smith E.O., Roth R.H., Charney D.S., Hoffer P.B., Innis R.B. Spect imaging of dopamine and serotonin transporters with [I-123] beta-Cit - pharmacological characterization of brain uptake in nonhuman-primates. Synapse 1993, 13:295-309.
13. 11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography. Life Sciences 1996, 58(PL):187-192.
14. Makkonen I., Riikonen R., Kokki H., Airaksinen M.M., Kuikka J.T. Serotonin and dopamine transporter binding in children with autism determined by SPECT. Developmental Medicine and Child Neurology 2008, 50:593-597.
15. Mawlawi O., Huang Y., Hwang D.R., Martinez D., Lombardo I., Slifstein M., Amstel D., Eftychiou N., Gelbard I., Van Heertum R., Abi-Dargham A., Laruelle M. Mapping 5HT2A receptors in human brain with (11)CMDL100907: validation and reproducibility. Journal of Nuclear Medicine 2001, 42:106P-P.
16. Mawlawi O., Martinez D., Slifstein M., Broft A., Chatterjee R., Hwang D.R., Huang Y., Simpson N., Ngo K., Van Heertum R., Laruelle M. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. Journal of Cerebral Blood Flow and Metabolism 2001, 21:1034-1057.
17. McBride P.A., Anderson G.M., Hertzig M.E., Sweeney J.A., Kream J., Cohen D.J., Mann J.J. Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. Archives of General Psychiatry 1989, 46:213-221.
18. McDougle C.J., Naylor S.T., Cohen D.J., Aghajanian G.K., Heninger G.R., Price L.H. Effects of tryptophan depletion in drug-free adults with autistic disorder. Archives of General Psychiatry 1996, 53:993-1000.
19. Murphy D.G., Daly E., Schmitz N., Toal F., Murphy K., Curran S., Erlandsson K., Eersels J., Kerwin R., Ell P., Travis M. Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. American Journal of Psychiatry 2006, 163:934-936.
20. Nakamura K., Sekine Y., Ouchi Y., Tsujii M., Yoshikawa E., Futatsubashi M., Tsuchiya K.J., Sugihara G., Iwata Y., Suzuki K., Matsuzaki H., Suda S., Sugiyama T., Takei N., Mori N. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Archives of General Psychiatry 2010, 67:59-68.
21. Neumeyer J.L., Wang S.Y., Milius R.A., Baldwin R.M., Zeaponce Y., Hoffer P.B., Sybirska E., Altikriti M., Charney D.S., Malison R.T., Laruelle M., Innis R.B. [I-123] 2-beta-carbomethoxy-3-beta-(4-Iodophenyl)tropane - high-affinity spect radiotracer of monoamine reuptake sites in brain. Journal of Medicinal Chemistry 1991, 34:3144-3146.
22. 11C]McN 5652. Journal of Nuclear Medicine 2000, 41:1465-1477.
23. Szabo Z., McCann U.D., Wilson A.A., Scheffel U., Owonikoko T., Mathews W.B., Ravert H.T., Hilton J., Dannals R.F., Ricaurte G.A. Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions. Journal of Nuclear Medicine 2002, 43:678-692.
24. Talvik-Lotfi M., Nyberg S., Nordstrom A.L., Ito H., Halldin C., Brunner F., Farde L. High 5HT2A receptor occupancy in M100907-treated schizophrenic patients. Psychopharmacology (Berl) 2000, 148:400-403.
25. Wilson A.A., Ginovart N., Schmidt M., Meyer J.H., Threlkeld P.G., Houle S. Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines. Journal of Medicinal Chemistry 2000, 43:3103-3110.